Skip to main content
VCbacked
Log inGet Started

InnAVasc Medical

Durham, United States

InnAVasc Medical is a medical device company that designs and develops products for vascular access for hemodialysis.

$1.0M raised
Nov 2021
Debt Financing
Health CareManufacturingMedicalMedical Device

Top Investors

National Science FoundationNorth Carolina Biotechnology CenterDuke Angel NetworkPilot Mountain Ventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about InnAVasc Medical

How much funding has InnAVasc Medical raised?
InnAVasc Medical has raised $1.0M in total funding. The most recent round was Debt Financing. The last funding was announced in November 2021.
Who are InnAVasc Medical's investors?
InnAVasc Medical's investors include National Science Foundation, North Carolina Biotechnology Center, Duke Angel Network, Pilot Mountain Ventures.
Where is InnAVasc Medical headquartered?
InnAVasc Medical is headquartered in Durham, United States.
What does InnAVasc Medical do?
InnAVasc Medical is a medical device company that designs and develops products for vascular access for hemodialysis.
What stage is InnAVasc Medical at?
InnAVasc Medical is at the Debt Financing stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"InnAVasc Medical — Funding & Investors." VCBacked, November 9, 2021, https://www.vcbacked.co/company/innavasc-medical. Accessed July 2, 2026.
APA
VCBacked. (2021). InnAVasc Medical — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/innavasc-medical
Wikipedia (cite web)
{{cite web |title=InnAVasc Medical — Funding & Investors |url=https://www.vcbacked.co/company/innavasc-medical |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Oryl Photonics
Lausanne
Allterum Therapeutics
Houston$1.0M
OncoRevive
Brunswick$119K
Rapport Therapeutics
Boston$250.0M
YLAH
Bern$589K
Novostia
Epalinges$6.6M